Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07371520

Application of Quantitative Hemorrhage Detection in Fetomaternal Hemorrhage Syndrome for the Diagnosis of Hemolytic Disease of the Newborn

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study adopted a single-center, prospective, observational study design. A consecutive cohort of pregnant and postpartum women who met the inclusion criteria was recruited from Shanghai First People's Hospital between January 2026 and December 2028. Quantitative hemorrhage detection was performed using residual clinical blood samples, and the diagnostic value of this detection for hemolytic disease of the newborn (HDN) was analyzed.

Conditions

Timeline

Start date
2026-03-01
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2026-01-28
Last updated
2026-02-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07371520. Inclusion in this directory is not an endorsement.

Application of Quantitative Hemorrhage Detection in Fetomaternal Hemorrhage Syndrome for the Diagnosis of Hemolytic Dise (NCT07371520) · Clinical Trials Directory